Development of antihypertensive drugs: L-arginine and its derivatives as a precursor of endothelium-derived relaxing factor
抗高血压药物的开发:L-精氨酸及其衍生物作为内皮源性舒张因子的前体
基本信息
- 批准号:03557012
- 负责人:
- 金额:$ 7.49万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Developmental Scientific Research (B)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1992
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Intravenous administration of L-arginine to normotensive healthy volunteers caused a slight reduction of systemic blood pressure. To essential and secondary hypertension it caused a marked decrease in systemic blood pressure. Based on observations of the increase in plasma cyclic GMP and citrulline, as well as urinary nitrite/nitrate and increased output of nitric oxide from cultured endothelial cells, the antihypertensive effect of L-arginine was probably due to an increase in nitric oxide synthesis/release in vivo. L-arginine suppressed plasma aldosterone. These results suggest that exogenous L-arginine produces a vasodilatory effect by increasing NO production and that L-arginine or released NO modulates the release of neuroendocrine hormones in hypertensive subjects.
正常血压的健康志愿者静脉注射L-精氨酸可使全身血压轻微降低。对原发性和继发性高血压,它引起全身血压显着下降。根据对血浆环GMP和瓜氨酸增加以及尿亚硝酸盐/硝酸盐和培养内皮细胞一氧化氮输出增加的观察,L-精氨酸的降压作用可能是由于体内一氧化氮合成/释放增加。L-精氨酸抑制血浆醛固酮。这些结果表明,外源性L-精氨酸产生血管舒张作用,通过增加NO的产生和L-精氨酸或释放NO调节高血压受试者的神经内分泌激素的释放。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K. Hishikawa, T. Nakaki, H. Suzuki, T. Saruta and R. Kato: "Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man" Jpn. Heart J.33. 41-48 (1992)
K. Hishikawa、T. Nakaki、H. Suzuki、T. Saruta 和 R. Kato:“全身性 L-精氨酸给药对人体血流动力学和一氧化氮释放的影响”Jpn。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hishikawa,K.: "Effect of systemic L-arginine administration on hemodynamic and nitric oxide release in man" Jpn.Heart J.(1992)
Hishikawa,K.:“全身 L-精氨酸给药对人体血流动力学和一氧化氮释放的影响”Jpn.Heart J.(1992)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
SUZUKI,H.: "Increases in NO_2-NO_3- excreation in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure" Clin.Sci.82. 631-634 (1992)
SUZUKI,H.:“尿液中 NO_2-NO_3- 排泄的增加作为血压升高期间内皮衍生舒张因子释放的指标”Clin.Sci.82。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Suzuki, H. Ikenaga, K. Hishikawa, T. Nakaki, R. Kato and T. Saruta: "Increases in NO2^-/NO3^- excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure." Clin Sci. 82. 631-634 (1992)
H. Suzuki、H. Ikenaga、K. Hishikawa、T. Nakaki、R. Kato 和 T. Saruta:“尿液中 NO2^-/NO3^- 排泄量的增加是内皮源性松弛因子释放的指标
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Hishikawa, T. Nakaki, H. Suzuki, T. Saruta and R. Kato: "L-arginine-induced hypotension" Lancet. 337. 683-684 (1991)
K. Hishikawa、T. Nakaki、H. Suzuki、T. Saruta 和 R. Kato:“L-精氨酸引起的低血压”《柳叶刀》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAKI Toshio其他文献
NAKAKI Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAKI Toshio', 18)}}的其他基金
A study on CNS oxidative stress-resistant mouse
中枢神经系统氧化应激抵抗小鼠的研究
- 批准号:
21590291 - 财政年份:2009
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of an alpha-lb adrenoceptor antagonist on methamphetamine-induced neuronal toxicity
α-1b肾上腺素受体拮抗剂对甲基苯丙胺诱导的神经元毒性的影响
- 批准号:
17590228 - 财政年份:2005
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rotenone-Induced Parkinsonism
鱼藤酮诱发的帕金森病
- 批准号:
14570088 - 财政年份:2002
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Implications of nitrocathecholamines in Parkinson's disease
硝基儿茶酚胺对帕金森病的影响
- 批准号:
12680760 - 财政年份:2000
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on a novel endogenous catecholamine, 6-nitronorepinephrine
新型内源性儿茶酚胺6-硝基去甲肾上腺素的研究
- 批准号:
09680771 - 财政年份:1997
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Development of new antihypertensive drug by comprehensive analysis of WNK signal
综合分析WNK信号开发降压新药
- 批准号:
20K17244 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects and Mechanisms of Nutrition Management and Antihypertensive drug administration for Nonalcoholic Steatohepatitis
营养管理和降压药物治疗对非酒精性脂肪性肝炎的作用及机制
- 批准号:
19K20197 - 财政年份:2019
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Antitumor effects of lifestyle drugs on colorectal cancer: Involvement of antihypertensive drug ARB as a novel chemopreventive agent
生活方式药物对结直肠癌的抗肿瘤作用:抗高血压药物 ARB 作为新型化学预防剂的参与
- 批准号:
18K11023 - 财政年份:2018
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimization of combination therapy with antihypertensive drug to ameliorate side effects of multilinase inhibitors in kidney cancer
优化降压药物联合治疗以改善多酶抑制剂治疗肾癌的副作用
- 批准号:
15K08100 - 财政年份:2015
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Population studies regarding genetic background on progression of hypertension and antihypertensive drug effect based on self-measured home blood pressure
基于自测家庭血压的高血压进展遗传背景和降压药物疗效的人群研究
- 批准号:
25253059 - 财政年份:2013
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Genome-wide case-only study of antihypertensive drug-gene interactions
抗高血压药物-基因相互作用的全基因组病例研究
- 批准号:
7494142 - 财政年份:2007
- 资助金额:
$ 7.49万 - 项目类别:
Genome-wide case-only study of antihypertensive drug-gene interactions
抗高血压药物-基因相互作用的全基因组病例研究
- 批准号:
7258677 - 财政年份:2007
- 资助金额:
$ 7.49万 - 项目类别:
Genome-wide case-only study of antihypertensive drug-gene interactions
抗高血压药物-基因相互作用的全基因组病例研究
- 批准号:
7631351 - 财政年份:2007
- 资助金额:
$ 7.49万 - 项目类别:
Genome-wide case-only study of antihypertensive drug-gene interactions
抗高血压药物-基因相互作用的全基因组病例研究
- 批准号:
7898752 - 财政年份:2007
- 资助金额:
$ 7.49万 - 项目类别: